The WHO estimates that there were 484,000 new cases with resistance to rifampicin, the most effective first-line drug, of which 78% had multidrug-resistant TB (MDR-TB). TB usually affects the ...

Drug resistance is one of the greatest challenges in cancer treatment. Therefore, understanding its mechanisms is essential for developing new therapies. The study also identified methods to ...

However, the emergence of drug-resistant strains of HIV-1 poses significant challenges to treatment. Recent research has focused on understanding the mechanisms behind this drug resistance ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts," the authors wrote. Rifampicin is a key drug recommended by the World Health Organisation as first-line ...

"The term Multi Drug Resistant Tuberculosis (MDR TB) is used when the bacteria get resistant to Isoniazid and Rifampicin, the two most important drugs used during treatment." When Does Multi-Drug ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts." Rifampicin is a key drug recommended by the World Health Organisation as a first-line treatment for TB.